WNT3A and breast cancer: Using patient-derived cell samples from both ER+ve (n = 3) and ER-ve (n = 3) breast cancer and normal breast tissue (n = 3) we found that WNT3A caused a significant increase in MS only in the ER-ve sample (Figure 5C).